Tag: Enhertu
-

Enhertu’s Phase 3 Win: AI Accelerates Lung Cancer Treatment
Enhertu’s Phase 3 trial success in treating lung cancer highlights the critical role AI played in optimizing the drug’s development. This marks a significant step in personalized medicine, offering new hope for targeted cancer treatments. Read more
